A microfluidic platform for the characterisation of CNS active compounds
MacKerron, Christopher and Robertson, Graham and Zagnoni, Michele and Bushell, Trevor (2017) A microfluidic platform for the characterisation of CNS active compounds. Scientific Reports. ISSN 2045-2322 (https://doi.org/10.1038/s41598-017-15950-0)
Preview |
Text.
Filename: MacKerron_etal_SR_2017_A_microfluidic_platform_for_the_characterisation_of_CNS_active_compounds.pdf
Final Published Version License: Download (2MB)| Preview |
Abstract
New in vitro technologies that assess neuronal excitability and the derived synaptic activity within a controlled microenvironment would be beneficial for the characterisation of compounds proposed to affect central nervous system (CNS) function. Here, a microfluidic system with computer controlled compound perfusion is presented that offers a novel methodology for the pharmacological profiling of CNS acting compounds based on calcium imaging readouts. Using this system, multiple applications of the excitatory amino acid glutamate (10 nM - 1 mM) elicited reproducible and reversible transient increases in intracellular calcium, allowing the generation of a concentration response curve. In addition, the system allows pharmacological investigations to be performed as evidenced by application of glutamatergic receptor antagonists, reversibly inhibiting glutamateinduced increases in intracellular calcium. Importantly, repeated glutamate applications elicited significant increases in the synaptically driven activation of the adjacent, environmentally isolated neuronal network. Therefore, the proposed new methodology will enable neuropharmacological analysis of CNS active compounds whilst simultaneously determining their effect on synaptic connectivity.
ORCID iDs
MacKerron, Christopher ORCID: https://orcid.org/0000-0002-8741-5078, Robertson, Graham ORCID: https://orcid.org/0000-0002-3841-874X, Zagnoni, Michele ORCID: https://orcid.org/0000-0003-3198-9491 and Bushell, Trevor ORCID: https://orcid.org/0000-0003-4145-9670;-
-
Item type: Article ID code: 62254 Dates: DateEvent16 November 2017Published16 November 2017Published Online3 November 2017AcceptedSubjects: Technology > Electrical engineering. Electronics Nuclear engineering
Medicine > Therapeutics. PharmacologyDepartment: Faculty of Engineering > Electronic and Electrical Engineering
Technology and Innovation Centre > Advanced Science and Technology
Technology and Innovation Centre > Bionanotechnology
Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical SciencesDepositing user: Pure Administrator Date deposited: 07 Nov 2017 11:49 Last modified: 12 Nov 2024 01:54 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/62254